James Markert

12PUBLICATIONS
63CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 16, 2025
Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel Immunotherapies.

Carlos A Gallegos, Benjamin P Lee, Benjamin B Kasten

|Jul 04, 2025
The effect of antidepressants on glioblastoma survival: A systematic review and meta-analysis.

Yifei Sun, Mohammad Hamo, Travis Atchley

|Apr 24, 2025
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity.

Upasana Sahu, Matthew P Mullarkey, Sara A Murphy

|Jan 30, 2025
Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma.

Jeffrey M Grimes, Sadashib Ghosh, Shamza Manzoor

|May 06, 2024
Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent.

Stacie K Totsch, Andrew S Ishizuka, Kyung-Don Kang

|Aug 12, 2023
Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults.

Meagan Mandabach Olivet, Michael C Brown, Zachary J Reitman

Pageof 2

Frequent Collaborators

2 joint publications

Joshua D Bernstock

2 joint publications

Sam E Gary

2 joint publications

Kyung-Don Kang

2 joint publications

Gregory K Friedman